Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to include ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback